SPONSORS AND EXHIBITORS MAIN MAJOR Programme book CIS - INDUSTRY SPONSORED SYMPOSIA OCTOBER 5-8 www.ever.be EVER K SIS - SPECIAL INTEREST SYMPOSIA boo MME A R G 2016 in conjunction ro EUPO EXHIBITORS Science for Sight course with EVER CAMBRIDGE RESEARCH SYSTEMS NICE EVER 2016 P EVER 2016 THANK YOU EVER would like to thank all of its past and present sponsors We would especially like to thank the following companies, many of which are our long-term supporters, for their generous sponsorship in 2016 Thanks to their kind support EVER can continue to encourage research and dissemination of knowledge concerning the eye and vision by means of meetings, publications and exchange of information EVER 2016 - programme book 22 CME XEN_Advertisement_A4 portrait_Ever2016 programme.indd 1 Find alist of countries where XEN is available at the Allergan stand. Adverse events should be reported to your local regulatory authority and Allergan office. XENDate is ofnot preparation:commercially July available 2016 INT/0457/2016a XEN in France. is amedical device class III CE 0086. Please consult your local directions for use. The power of simplicity Rethink glaucoma management glaucoma Rethink 09/08/2016 10:59 HERMES RHODES 1 RHODES 2 RHODES 3 RHODES 4 GALLIENI 1&2 GALLIENI 4 GALLIENI 5 Friday, October 7, 2016 08:30 - 10:00 RV - Confrontation of G - New technologies in COS - Nanotechnology in PO - Conjunctival tumors EUPO 1 LC - Ocular damage from ACB - Stem cells and MBGE - Grand rounds in OCT-angiography and glaucoma surgery ophthalmology Neuro-ophthalmology ambient optical radiation cell therapy advances in ophthalmic genetics fluoresceine angiography ophthalmology POURNARAS C - VANDEWALLE E - COUPLAND S - ZOGRAFOS L STALMANS I KOMPELLA UB - GRIFFITH M CAUJOLLE JP SÖDERBERG P - WEGENER A PETROVSKI G - MOE M LEROY B - HAMEL C 10:10 - 10:40 Keynote Lecture: OPA1 gene and mitochondrial optic neuropathy: disease mechanisms and potential therapies - VOTRUBA M Hermes 10:40 - 11:00 Coffee break Exhibition area 11:00 - 12:30 ARVO@EVER - Animals in RV - FP session - COS - FP session - Corneal PO - Controversies in EUPO 2 PO/IM - Cytology of IM - FP session - Nov- MBGE/LC - Radiation ocular oncology AMD & miscellaneous transplantation from the posterior uveal Neuro-ophthalmology atypical inflammation or elties in diagnosis and induced cataracts tumors treatment in ocular lab to the OR melanoma immunology VAN GINDERDEUREN R - COUPLAND S SOUBRANE G - LEYS A GICQUEL J - FUCHSLUGER T MOURIAUX F - CASSOUX N VAN CALSTER J BODAGHI B - WILLERMAIN F AINSBURY L - WEGENER A 13:30 - 15:00 RV - Retinal detachment G - EVER Obergurgl optic COS/RV - Emerging PO - Topical and EUPO 3 EOVS - FP session - IM - How to publish your MBGE - FP session nerve meeting intravitreal pharma- solutions in Neuro-ophthalmology Electrophysiology - scientific work? symposium: the ageing ophthalmology cotherapy in ocular optic nerve oncology protocols & applications GRUS F - CROWSTON J - FUCHSLUGER T - ZOGRAFOS L - CASTELO-BRANCO M - BUJAKOWSKA K - POURNARAS JA - E MER Y MARTIN K STEFANSSON E DESJARDINS L KRASTEL H PLEYER U SCHWARZ N 15:00 - 16:00 Poster session2: Neuro-ophthalmology / Strabismology / Paediatric/History • Retina / Vitreous Poster area 16:00 - 16:30 Business meeting RV Business meeting EOVS / G Business meeting COS / NSPH Business meeting PO / PBP EUPO 4 Business meeting IM / MBGE Business meeting ACB Business meeting LC 16:30 - 18:00 FAN Club G - Implications of COS - Corneal OOG Session 1 Neuro-ophthalmology PBP - Ocular pulse IM - FP session - New in- GOA - Update on severe Case presentations neuro-glial interactions neovascularization and amplitude - from pole to sights in imaging in ocular allergic conjunctivitis in neurodegenerative immune privilege pole immunology diseases KOLKO M - KIVELÄ T - ABEGAO PINTO L - BREMOND-GIGNAC D - WAAGEPETERSEN H HORI J - CHEN L - ZHANG H HADJISTILIANOU T MARQUES-NEVES C HERBORT CP - NERI P FAUQUERT J 18:00 - 18:30 EVER General Assembly Hermes Saturday, October 8, 2016 08:30 - 10:00 NSPH/RV - The first ones COS - Keratoconus COS - Corneal infectious OOG Session 2 & EUPO 5 FRO: Belgian Fund for in ophthalmology diagnosis and treatment diseases Business Meeting Strabismus Research in in the clinical practice Ophthalmology - part 1 SZENTMARY N - GICQUEL J - TASSIGNON MJ - GRZYBOWSKI A - ASCASO F ZSOLT NAGY Z BREMOND-GIGNAC D HEEGAARD S - CASSOUX N CASPERS L 10:00 - 10:20 Coffee break Exhibition area EUPO 6 10:20 - 10:50 Ophthalmic Research Lecture: The cataract surgeon and the anterior interface - TASSIGNON M-J Strabismus Hermes 10:50 - 12:00 Poster session 3: Anatomy / Cell Biology • Cornea / Ocular Surface • Immunology / Microbiology Lens and Cataract • Pathology / Oncology Poster area 12:00 - 13:00 Lunchtime Women 4 EVER COS - Pseudophakic and COS - Maximising success OOG Session 3 FRO: Belgian Fund for 13:00 - 14:30 EUPO 7 phakic toric implants – in deep anterior lamellar Research in from preoperative keratoplasty Strabismus Ophthalmology - part 2 examination LANGENBUCHER A - ZOGRAFOS L - TASSIGNON MJ - Creuzot C SZENTMARY N - EPPIG T DUA H S - GICQUEL J DESJARDINS L CASPERS L 14:30 - 15:00 Prize Award Ceremony & Closing Remarks Hermes EVER 2016 Word from the President Dear EVER members, colleagues and friends, 2016 heralds an exciting and animated month of October as EVER and EUPO (the European Professors of Ophthalmology group) come together for a grand event. This meeting is not to be missed! As in previous years, EVER offers a varied menu of fundamental fare and house specialties. These in- clude board preparation sessions, clinical courses, topic-specific symposia, state-or-the-art research platforms, keynote lectures and a broad palette of scientific posters The “extra” in 2016 will be the EUPO courses dedicated to neuro-ophthalmology and strabismus. These are CME accredited courses which will run in parallel with the EVER scientific program during Friday and Saturday (October 7-8). EUPO courses are intended to assist the preparation of young ophthalmologists for the European Board of Ophthalmology examination and also serve as excellent refresher courses for any practicing ophthalmologist. I am delighted to announce that EVER offers open general admission to EUPO courses for all EVER meeting registrants (without an increase in registration fee from the previous year!). Likewise, EUPO attendees will have open access to the EVER program on those 2 shared days. And as EVER and EUPO boast a strong international faculty, this is a win-win situation for all! At EVER, we strive for growth, advancement and improvement in ophthalmology and visual science. This may sound like the oft-heard rally cry of “more, bigger and better” which, in practice, often trans- lates to harried, stressed and rushed. Rest assured that EVER is none of that. The beautiful relaxed atmosphere of the French Riviera is once again home to the EVER meeting. Over 4 sunny days in Nice, after the scientific day, enjoy a stroll through the fresh market , take a dip in the Mediterranean waters and savor tasty gourmet dishes on an open terrace. So join me at EVER-EUPO 2016. It will be a stimulating experience! Aki KAWASAKI President EVER 2016 EVER 2016 - programme book 1 L’innovation en Ophtalmologie va bien au-delà des médicaments Téléchargez l’Application Retina Base pour tablettes tactiles sur l’App Store® ou le Google Play® et découvrez plus de 120 cas cliniques de pathologies rétiniennes rédigés par des experts, disponibles en Français et en Anglais. • NNaviguez à travers l’organisation planétaire des pathologies et ccas cliniques. • RRecherchez facilement les clichés grâce au moteur de rrecherche intuitif et ltrez les résultats par mot-clé, technique dd’imagerie et auteur. • RRecevez les noti cations dès que de nouveaux cas sont ddisponibles. Rendez-vous sur www.viaopta.fr pour découvrir ou redécouvrir tous les services ViaOpta™ dédiés à l’ophtalmologie C65306 - Août 2014 Votre partenaire en Ophtalmologie C65306 ViaOpta_210x297.indd 1 06/04/2016 11:44 EVER 2016 Table of contents Word from the president ....................................................................................................................................1 About EVER ..........................................................................................................................................................4 Composition of the board 2016 .........................................................................................................................8 Congress information ....................................................................................................................................... 10 Grants and prizes ..............................................................................................................................................14 Floorplan ............................................................................................................................................................16 Partners of EVER ...............................................................................................................................................18 About the programme book ............................................................................................................................20 Scientific sections 2016 .....................................................................................................................................21 Industry Sponsored Symposia ........................................................................................................................22